VERTEX PHARMACEUTICALS INC / MA Deferred Tax Assets, Net of Valuation Allowance, Current
VERTEX PHARMACEUTICALS INC / MA (VRTX) had Deferred Tax Assets, Net of Valuation Allowance, Current of $0 as of 2015-12-31, per its 10-K filed 2016-02-16.
Discontinued › Notes › Income Taxes
us-gaap:DeferredTaxAssetsNetCurrent · last filed 2016-02-16
- 2015-12-31: Deferred Tax Assets, Net of Valuation Allowance, Current $0.00.
- 2014-12-31: Deferred Tax Assets, Net of Valuation Allowance, Current $3.50M.
- 2013-12-31: Deferred Tax Assets, Net of Valuation Allowance, Current $0.00.
| Period end | Deferred Tax Assets, Net of Valuation Allowance, Current |
|---|---|
| 2015-12-31 | $0.00 10-K · filed 2016-02-16 |
| 2014-12-31 | $3.50M 10-K · filed 2016-02-16 |
| 2013-12-31 | $0.00 10-K · filed 2015-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |